Envista Holdings Corporation

NVST Healthcare Medical Instruments & Supplies

Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024. In the quarter to June 2026, revenue grew 7.10%, EPS grew 106.3%, free cash flow grew 37.6% and total debt was flat, each against the same quarter a year earlier.

22.90 0.60 −2.55%
Market cap
$3.8B
P/E
38.8×
Fwd P/E
24.4×
Dividend yield
—
F-score
7/9
Altman Z
1.59
Beneish M
−2.50
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
44.66 60.40 77.54 226.33

+8 more quarters

P/S ratio
1.49 1.48 1.34 1.29
P/FCF ratio
17.13 18.87 15.80 12.86
P/Operating CF
35.79 (1,260.04) 33.77 42.99
P/B ratio
1.39 1.35 1.17 1.10
EV/Sales
1.64 1.65 1.47 1.45
EV/EBITDA
10.94 11.68 10.78 11.14
EV/FCF
18.85 21.02 17.32 14.49
Current Ratio
2.43 2.44 2.38 2.37
Net Debt/EBITDA
2.62 3.50 2.11 3.23
Debt/Equity
0.47 0.47 0.47 0.47
Earnings Yield
2.24% 1.66% 1.29% 0.44%
Free Cash Flow Yield
5.84% 5.30% 6.33% 7.78%
Free Cash Flow per Share
0.65 (0.10) 0.55 0.41
Book value per Share
19.00 18.79 18.49 18.59
Free Cash Flow
105.10 (15.70) 91.70 67.90
EV/EBIT
17.15 19.33 18.51 20.18
Other line items

Show all line items

Columns are period end dates